| Kris A Ford, DPM | |
|
102 Palo Alto Rd, Suite 133, San Antonio, TX 78211-3758 | |
| (210) 923-9200 | |
| (210) 923-9202 |
| Full Name | Kris A Ford |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 16 Years |
| Location | 102 Palo Alto Rd, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023269925 | NPI | - | NPPES |
| 8BT932 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1954 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Medical Center | San antonio, TX | Hospital |
| Lavaca Medical Center | Hallettsville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lavaca Hospital District | 1153211750 | 21 |
| South Alamo Foot And Ankle Pllc | 9133484629 | 2 |
News Archive
GlobalMed today announced it is partnering with HP to introduce three new mobile telemedicine carts and a tablet PC solution powered by HP Workstations and EliteBook PCs that will bring doctors and patients together for clinical healthcare at a distance.
Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.
Guardant Health today announced new clinical utility data for its Guardant360 platform, which will be presented at the 2015 American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.
Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce that Dr. Pierce D. Nunley, Director of the Spine Institute of Louisiana, will present his abstract, "A Comparison of Clinical Outcomes and Adjacent Level Fractures in Patients Receiving Vertebroplasty for Osteoporotic Compression Fractures Using CortossTM or PMMA: A Prospective, Randomized Trial," at the 2009 Annual Meeting of the Congress of Neurological Surgeons (CNS).
› Verified 8 days ago
| Provider Name | Lavaca Hospital District |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1245274471 PECOS PAC ID: 1153211750 Enrollment ID: O20040317001233 |
News Archive
GlobalMed today announced it is partnering with HP to introduce three new mobile telemedicine carts and a tablet PC solution powered by HP Workstations and EliteBook PCs that will bring doctors and patients together for clinical healthcare at a distance.
Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.
Guardant Health today announced new clinical utility data for its Guardant360 platform, which will be presented at the 2015 American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.
Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce that Dr. Pierce D. Nunley, Director of the Spine Institute of Louisiana, will present his abstract, "A Comparison of Clinical Outcomes and Adjacent Level Fractures in Patients Receiving Vertebroplasty for Osteoporotic Compression Fractures Using CortossTM or PMMA: A Prospective, Randomized Trial," at the 2009 Annual Meeting of the Congress of Neurological Surgeons (CNS).
› Verified 8 days ago
| Provider Name | South Alamo Foot & Ankle Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417446642 PECOS PAC ID: 9133484629 Enrollment ID: O20180604002943 |
News Archive
GlobalMed today announced it is partnering with HP to introduce three new mobile telemedicine carts and a tablet PC solution powered by HP Workstations and EliteBook PCs that will bring doctors and patients together for clinical healthcare at a distance.
Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.
Guardant Health today announced new clinical utility data for its Guardant360 platform, which will be presented at the 2015 American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.
Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce that Dr. Pierce D. Nunley, Director of the Spine Institute of Louisiana, will present his abstract, "A Comparison of Clinical Outcomes and Adjacent Level Fractures in Patients Receiving Vertebroplasty for Osteoporotic Compression Fractures Using CortossTM or PMMA: A Prospective, Randomized Trial," at the 2009 Annual Meeting of the Congress of Neurological Surgeons (CNS).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kris A Ford, DPM 45 Ne Loop 410, Suite 485, San Antonio, TX 78216-5832 Ph: (210) 227-8700 | Kris A Ford, DPM 102 Palo Alto Rd, Suite 133, San Antonio, TX 78211-3758 Ph: (210) 923-9200 |
News Archive
GlobalMed today announced it is partnering with HP to introduce three new mobile telemedicine carts and a tablet PC solution powered by HP Workstations and EliteBook PCs that will bring doctors and patients together for clinical healthcare at a distance.
Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.
Guardant Health today announced new clinical utility data for its Guardant360 platform, which will be presented at the 2015 American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.
Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce that Dr. Pierce D. Nunley, Director of the Spine Institute of Louisiana, will present his abstract, "A Comparison of Clinical Outcomes and Adjacent Level Fractures in Patients Receiving Vertebroplasty for Osteoporotic Compression Fractures Using CortossTM or PMMA: A Prospective, Randomized Trial," at the 2009 Annual Meeting of the Congress of Neurological Surgeons (CNS).
› Verified 8 days ago
Thomas Zgonis, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 7726 Louis Pasteur Dr, San Antonio, TX 78229 Phone: 210-575-3327 Fax: 210-575-7699 | |
Michael Lee Dempsey, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7500 Barlite Blvd, Suite 311, San Antonio, TX 78224 Phone: 210-572-9255 Fax: 210-572-9256 | |
Del Rio Foot Clinic P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 94 Briggs St Ste 600, San Antonio, TX 78224 Phone: 210-872-3668 Fax: 210-428-6317 | |
South Texas Foot Surgeons, P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 5282 Medical Dr, Suite 260, San Antonio, TX 78229 Phone: 210-616-0819 Fax: 210-692-9529 | |
Mohammad-asad Buksh Ilahi, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 701 S Zarzamora St, San Antonio, TX 78207 Phone: 210-358-7402 | |
Dr. Evan F. Meltzer, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 7400 Merton Minter St, Audie L. Murphy Vamc, San Antonio, TX 78229 Phone: 210-617-5300 |